Secondary rectal cancer tumors that develop years after prostate cancer radiation therapy appear to differ in distinct ways from primary rectal cancers.

JAMAICANS are being encouraged to screen for colorectal cancer, as it continues to be an increasing cause of death on the ...

Stand Up To Cancer takes developments from the lab and accelerates them into new tests and treatments for those that need ...

"Residual cancer is identified on histology in 40% of lung, 57–69% of renal cell, 7.7–47.6% of prostate and 0–86.7% of hepatocellular carcinoma." ...

Our novel approach effectively predicts rectal toxicity across photon and proton subsets ... Supported by Massachusetts General Hospital federal share program (M.M. and J.A.C), by Prostate Cancer ...

Residual cancer can remain undetected despite clear scans, potentially leading to worse outcomes and higher risks of ...

Glasgow rectal cancer survivor Tracey Farrell has welcomed a £5.5 million investment into bowel cancer research by Cancer Research UK and partners.

Radiotherapy may leave behind microscopic cancer even when scan images suggest the tumour is gone, and this “residual disease ...

While radiotherapy is a highly effective cancer treatment -- useful for about 60 per cent of all cancers -- it may lead to residual cancer that has the potential to hide behind clear scans and lead ...

Radiotherapy, especially a form known as stereotactic ablative radiotherapy (SABR), is widely used to treat cancers in the ...